Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
2020 · Journal of Experimental & Clinical Cancer Research · 243 citations
https://doi.org/10.1186/s13046-020-01601-2
F
Fabrizio Citarella
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
98
Papers
1.7K
Citations
23
h-index
32
i10-index
Fabrizio Citarella is an academic researcher from Università Campus Bio-Medico. The author has contributed to research in topics: Lung Cancer Treatments and Mutations & Cancer Immunotherapy and Biomarkers & Lung Cancer Research Studies. The author has an h-index of 23, co-authored 84 publications.
ORCID: 0000-0003-3096-4452Papers by this author
worksBaseline BMI and BMI variation during first line pembrolizumab in NSCLC patients with a PD-L1 expression ≥ 50%: a multicenter study with external validation
2020 · Journal for ImmunoTherapy of Cancer · 100 citations
https://doi.org/10.1136/jitc-2020-001403
Sotorasib in KRASp.G12C mutated advanced NSCLC: Real-world data from the Italian expanded access program
2023 · Lung Cancer · 18 citations
https://doi.org/10.1016/j.lungcan.2023.107444
High familial burden of cancer correlates with improved outcome from immunotherapy in patients with NSCLC independent of somatic DNA damage response gene status
2022 · Journal of Hematology & Oncology · 13 citations
https://doi.org/10.1186/s13045-022-01226-2
Correction to: Liquid biopsy and tumor heterogeneity in metastatic solid tumors: the potentiality of blood samples
2020 · Journal of Experimental & Clinical Cancer Research · 11 citations
https://doi.org/10.1186/s13046-020-01615-w
MET exon 14 skipping mutations in non-small-cell lung cancer: real-world data from the Italian biomarker ATLAS database
2024 · ESMO Open · 8 citations
https://doi.org/10.1016/j.esmoop.2024.103680
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat